ESTIMATION OF CARDIOVASCULAR RISK IN PATIENTS WITH ULCERATIVE COLITIS ENROLLED IN UPADACITINIB PHASE 3 CLINICAL TRIALS
Laurent Peyrin-Biroulet 1
Raymond Cross 2
Kara M. De Felice 3
Dapo Ilo 4
Benjamin Duncan 4
Jinghui Liu 5
Cecile T. J. Holweg 4
Reezwana Chowdhury 6
1 Lorraine University, Vandoeuvre-lès-Nancy, France
2 University of Maryland, Baltimore, United States
3 University of Cincinnati, Cincinnati, United States
4 AbbVie, Inc., North Chicago, United States
5 Everest Clinical Research, Little Falls, United States
6 John Hopkins University, Baltimore, United States
Topic
IBD
Session
PP 05 IBD (Posters)
Conference
UEG Week 2023
Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]